Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin.
- 1 March 2001
- journal article
- research article
- Published by Springer Nature in Current Oncology Reports
- Vol. 3 (2) , 131-140
- https://doi.org/10.1007/s11912-001-0013-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dynamic CT measurement of cerebral blood flow: a validation study.1999
- Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialismAnnals of Oncology, 1998
- Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke.Radiology, 1998
- Non-invasive vascular imaging: assessing tumour vascularityEuropean Radiology, 1998
- Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma modelsCancer Chemotherapy and Pharmacology, 1998
- Clinical trials of antiangiogenic agentsCurrent Opinion in Oncology, 1997
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.1996
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995